Skip to main content

HIV and Aging: Osteoporosis in Older People with HIV

AAHIVM Course Banner
0.5 CEUs
HIV and Aging:
Osteoporosis in Older People with HIV

Module Description
If there is one constant in the field of HIV medicine, it is that of constant change. The science of HIV is an ever-changing landscape of new research findings, new medications with new targets and new side effects. Also, there are new populations affected by the epidemic, such as older adults. Because they face multiple comorbid conditions, older adults need a comprehensive care approach that accounts for the ongoing role of HIV and its treatment in the aging process. This approach should include assessment of overlapping geriatric syndromes, including frailty, disability, multi-morbidities and polypharmacy.

Credit Dates 08/25/23 – 08/24/24

Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine.

This activity is supported by independent educational grants from Merck & Co. and ViiV Healthcare.

Learning Objectives
  • Incorporate best strategies for screening and detection of HIV in older adults
  • Incorporate novel strategies for long-term management of HIV in older persons into clinical practice
  • Utilize best practices strategies to care for and treat common co-morbid conditions in HIV
  • Review the screening and treatment recommendations for osteoporosis since older adults with HV may suffer accelerated bone loss
Target Audience This activity is intended for physicians, physician assistants, nurse practitioners, nurses, and pharmacists who are engaged in the care of people with HIV.

Estimated Time to complete the Activity: 30 minutes 

PresenterBrian Wood, MD

Method  of Participation and Request for Credit

There are no fees for participating in and receiving CME/CE credit for this activity.

During the period from August 25, 2023 through August 24, 2024, participants must read the learning objectives and faculty disclosures and study the educational activity.

In order to obtain your CE credit please follow the steps below at the conclusion of the activity:

1. Visit
2. Enter your profile information
3. (If applicable) Complete the post-test with a passing score of 75% or better 
4. Complete the activity evaluation
5. Upon successfully completing the post test (if applicable) and activity evaluation, your certificate will be made available immediately. 

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the online evaluation form, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure your credit has posted. 

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education PACE designates this internet activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education PACE designates this continuing education activity for 0.5contact hours (0.05 CEUs) of Accreditation Council for Pharmacy Education.
(Universal Activity #JA4008073-9999-23-206-H02-P).
Type of Credit: Knowledge

Continuing Nursing Education The maximum number of hours awarded for this Continuing Nursing Education activity is0.5 contact hours, APRN 0.25 pharmacotherapy hours hours.

Disclosure of Conflict of Interest PACE requires instructors, planners, managers and other individuals who are in a position to the control  of this activity to disclose all their financial relationships with ineligible companies. All relevant relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationship to products or devices they have with ineligible companies related to the content of this activity. 

Dr. Wood has nothing to disclose. 

Planners and Managers
The PACE planners and managers have nothing to disclose.
The Academy planners and managers have nothing to disclose.

Media: Internet

Computer System Requirements: This program requires the use of an internet-connected computer or device capable of downloading and reading PDFs.

Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their individual patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.